S&P 500   3,105.13 (-0.48%)
DOW   27,781.67 (-0.55%)
QQQ   201.77 (-0.79%)
BABA   182.11 (-1.70%)
GE   11.37 (-1.13%)
T   36.91 (-2.87%)
ACB   2.61 (+11.54%)
F   8.70 (-2.25%)
BAC   32.59 (-1.06%)
DIS   146.48 (-1.28%)
S&P 500   3,105.13 (-0.48%)
DOW   27,781.67 (-0.55%)
QQQ   201.77 (-0.79%)
BABA   182.11 (-1.70%)
GE   11.37 (-1.13%)
T   36.91 (-2.87%)
ACB   2.61 (+11.54%)
F   8.70 (-2.25%)
BAC   32.59 (-1.06%)
DIS   146.48 (-1.28%)
S&P 500   3,105.13 (-0.48%)
DOW   27,781.67 (-0.55%)
QQQ   201.77 (-0.79%)
BABA   182.11 (-1.70%)
GE   11.37 (-1.13%)
T   36.91 (-2.87%)
ACB   2.61 (+11.54%)
F   8.70 (-2.25%)
BAC   32.59 (-1.06%)
DIS   146.48 (-1.28%)
S&P 500   3,105.13 (-0.48%)
DOW   27,781.67 (-0.55%)
QQQ   201.77 (-0.79%)
BABA   182.11 (-1.70%)
GE   11.37 (-1.13%)
T   36.91 (-2.87%)
ACB   2.61 (+11.54%)
F   8.70 (-2.25%)
BAC   32.59 (-1.06%)
DIS   146.48 (-1.28%)
Log in

Udg Healthcare Stock Price, Forecast & Analysis (OTCMKTS:UDHCF)

$9.55
+0.25 (+2.65 %)
(As of 10/24/2019)
Today's Range
$9.55
Now: $9.55
$9.55
50-Day Range
$9.30
MA: $9.42
$9.55
52-Week Range
$7.25
Now: $9.55
$9.86
Volume20,900 shs
Average Volume1,047 shs
Market Capitalization$2.37 billion
P/E Ratio20.75
Dividend YieldN/A
Beta0.49
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services. Read More…

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:UDHCF
CUSIPN/A
CIKN/A
Phone353-1468-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.32 billion
Cash Flow$0.71 per share
Book Value$3.56 per share

Profitability

Miscellaneous

Employees8,700
Market Cap$2.37 billion
Next Earnings Date12/17/2019 (Estimated)
OptionableNot Optionable

Receive UDHCF News and Ratings via Email

Sign-up to receive the latest news and ratings for UDHCF and its competitors with MarketBeat's FREE daily newsletter.


Udg Healthcare (OTCMKTS:UDHCF) Frequently Asked Questions

What is Udg Healthcare's stock symbol?

Udg Healthcare trades on the OTCMKTS under the ticker symbol "UDHCF."

When is Udg Healthcare's next earnings date?

Udg Healthcare is scheduled to release their next quarterly earnings announcement on Tuesday, December 17th 2019. View Earnings Estimates for Udg Healthcare.

What is the consensus analysts' recommendation for Udg Healthcare?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Udg Healthcare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Udg Healthcare.

Has Udg Healthcare been receiving favorable news coverage?

Press coverage about UDHCF stock has been trending very negative recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Udg Healthcare earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Udg Healthcare.

Who are some of Udg Healthcare's key competitors?

What other stocks do shareholders of Udg Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Udg Healthcare investors own include Orbit International (ORBT), Vanguard S&P Mid-Cap 400 ETF (IVOO), TEGNA (TGNA), Concho Resources (CXO), Pacira Biosciences (PCRX), LM Funding America (LMFA) and Intra-Cellular Therapies (ITCI).

Who are Udg Healthcare's key executives?

Udg Healthcare's management team includes the folowing people:
  • Mr. Brendan Patrick McAtamney, CEO & Exec. Director (Age 56)
  • Mr. Nigel Clerkin, CFO & Exec. Director (Age 45)
  • Mr. Mike O'Hara, MD & Pres
  • Mr. Jez Moulding, Exec. VP of Ashfield & COO
  • Keith Byrne, Head of Investor Relations, Strategy & Corp. Communications

How do I buy shares of Udg Healthcare?

Shares of UDHCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Udg Healthcare's stock price today?

One share of UDHCF stock can currently be purchased for approximately $9.55.

How big of a company is Udg Healthcare?

Udg Healthcare has a market capitalization of $2.37 billion and generates $1.32 billion in revenue each year. The company earns $3.80 million in net income (profit) each year or $0.46 on an earnings per share basis. Udg Healthcare employs 8,700 workers across the globe.View Additional Information About Udg Healthcare.

What is Udg Healthcare's official website?

The official website for Udg Healthcare is http://www.udghealthcare.com/.

How can I contact Udg Healthcare?

Udg Healthcare's mailing address is 20 Riverwalk Citywest Business Campus Citywest, Dublin L2, 24. The company can be reached via phone at 353-1468-9000 or via email at [email protected]


MarketBeat Community Rating for Udg Healthcare (OTCMKTS UDHCF)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  71 (Vote Outperform)
Underperform Votes:  124 (Vote Underperform)
Total Votes:  195
MarketBeat's community ratings are surveys of what our community members think about Udg Healthcare and other stocks. Vote "Outperform" if you believe UDHCF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UDHCF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel